Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation.

Wang H, Wen R, Yang Z, Yang L

Open source

DOI
10.1016/j.bcp.2026.118289
Published
2026 Nov
Container
Biochemical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118289,
  title = {Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation.},
  author = {Wang H and Wen R and Yang Z and Yang L},
  year = {2026},
  journal = {Biochemical pharmacology},
  doi = {10.1016/j.bcp.2026.118289},
  url = {https://doi.org/10.1016/j.bcp.2026.118289}
}

RIS

TY  - JOUR
TI  - Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation.
AU  - Wang H
AU  - Wen R
AU  - Yang Z
AU  - Yang L
PY  - 2026
JO  - Biochemical pharmacology
DO  - 10.1016/j.bcp.2026.118289
UR  - https://doi.org/10.1016/j.bcp.2026.118289
ER  - 

APA

H, W., R, W., Z, Y., & L, Y. (2026). Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118289

Source records